Roivant Sciences Ltd is trading 4% up today at $29.55 on improved risk sentiment, tracking broader gains across major U.S. indices.
- The advance occurs on elevated intraday interest despite the absence of new company-specific news or regulatory filings.
- The stock's performance appears primarily driven by the positive market backdrop rather than a fresh internal catalyst.